Alto Ingredients

Global Decarbonization And ISCC Exports Will Drive Bio-Based Success

AnalystHighTarget

Not Invested

Consensus Narrative from 2 Analysts

Published

26 Aug 25

Updated

26 Aug 25

AnalystHighTarget's Fair Value

US$5.50

79.3% undervalued

26 Aug

US$1.14

-17.4%

10.7%

-17.4%

10.7%

Author's Valuation

US$5.5

79.3% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

US$5.5

79.3% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

4.45%

Chemicals revenue growth rate

0.38%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

10.77%

Calculation

US$46.02m

Earnings '28

12.82x

PE Ratio '28

US$589.80m

Market Cap '28

US$589.80m

Market Cap '28

79.69m

No. shares '28

US$7.40

Share Price '28

US$7.40 Share Price '28

Discounted to 2025 @ 10.72% p.a.

US$5.45

Fair Value '25